The study “GP awareness about chemoprevention” was carried out on behalf of Cancer Research UK, and aimed to specifically explore GP awareness on tamoxifen and aspirin use with breast and bowel cancers.
The survey took place in May 2016 in the UK and involved over 1,000 physicians from our panel. You can access the study here and see a summary together with the main findings below.
Learn how a healthcare market research participant can confidently share clinical expertise, avoid common doubts, and provide valuable insights.
Researchers reveal how stromal barriers affect antibody-based therapies, mapping solid tumours at single-cell resolution.
Stage 2 chronic kidney disease often goes unnoticed, with estimated glomerular filtration rate levels still within the kidney function threshold.
